Table 2.
Author | Year | Selection | Comparability | Exposure | Total Score | |||||
---|---|---|---|---|---|---|---|---|---|---|
Adequate Definition of Patient Cases | Representativeness of Patient Cases | Selection of Controls | Definition of Controls | Control for Important or Additional Factors | Ascertainment of Exposure | Same method of Ascertainment for Participants | Nonresponse Rate | |||
Fabian [6] | 1993 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Townsend [7] | 1993 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Taner [8] | 2001 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Mathonnet [9] | 2003 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Omori [10] | 2003 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Mitsuhide [11] | 2005 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Huscher [12] | 2006 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Kaban [13] | 2008 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Mallat [14] | 2008 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 6 | ||
Shah [15] | 2011 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Johnson [16] | 2013 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Memon [18] | 2013 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Khubutiya [17] | 2013 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 6 | ||
Huang [19] | 2017 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Koto [23] | 2018 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 5 | |||
Parajuli [22] | 2017 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Lin [20] | 2018 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Matsevych [21] | 2018 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 | |
Nicolau [24] | 2019 | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 7 |
NOS, Newcastle-Ottawa scale; NRS, non-randomized study; ⋆, The study has met the criteria for a domain of the Newcastle-Ottawa Scale.